Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

País de afiliación
Intervalo de año de publicación
1.
Heliyon ; 9(11): e21425, 2023 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-38027672

RESUMEN

A nascent category of anticancer therapeutic drugs called antibody-drug conjugates (ADCs) relate selectivity of aimed therapy using chemotherapeutic medicines with high cytotoxic power. Progressive linker technology led to the advancement of more efficacious and safer treatments. It offers neoteric as well as encouraging therapeutic strategies for treating cancer. ADCs selectively administer a medication by targeting antigens which are abundantly articulated on the membrane surface of tumor cells. Tumor-specific antigens are differently expressed in breast and ovarian cancers and can be utilized to direct ADCs. Compared to conventional chemotherapeutic drugs, this approach enables optimal tumor targeting while minimizing systemic damage. A cleavable linker improves the ADCs because it allows the toxic payload to be distributed to nearby cells that do not express the target protein, operating on assorted tumors with dissimilar cell aggregation. Presently fifteen ADCs are being studied in breast and ovarian carcinoma preclinically, and assortment of few have already undergone promising early-phase clinical trial testing. Furthermore, Phase I and II studies are investigating a wide variety of ADCs, and preliminary findings are encouraging. An expanding sum of ADCs will probably become feasible therapeutic choices as solo agents or in conjunction with chemotherapeutic agents. This review accentuates the most recent preclinical findings, pharmacodynamics, and upcoming applications of ADCs in breast and ovarian carcinoma.

2.
Bol. latinoam. Caribe plantas med. aromát ; 9(5)sept. 2010. ilus, graf, tab
Artículo en Inglés | LILACS | ID: lil-613653

RESUMEN

A simple, precise and rapid high-performance thin-layer chromatographic method has been developed for the estimation of phyllanthin and is the important lignans of Phyllanthus amarus. Separation of phyllanthin was carried out on silica gel 60 F254 layers eluted with hexane: ethyl acetate (2:1), and the analytes were visualized through colour development with 10 percent concentrated sulphuric acid in ethanol. Scanning and quantification of spots was performed at 200 nm. The proposed method being precise and sensitive can be used for the detection, monitoring and quantification of phyllanthin from Phyllanthus amarus.


Un método simple, preciso y rápido de cromatografía de capa fina de alto rendimiento ha sido desarrollado para la estimación de phyllantina y los lignanos importante de Phyllanthus amarus. La separación de phyllantina se llevó a cabo en capas de silica gel 60 F254 eluidas con hexano: acetato de etilo (2:1), y los analitos fueron visualizados mediante el desarrollo de color con un 10 por ciento de ácido sulfúrico concentrado en etanol. Los análisis y cuantificación de los puntos se realizó a 200 nm. El método fue validado.


Asunto(s)
Cromatografía en Capa Delgada/métodos , Lignanos/análisis , Phyllanthus/química
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA